-
-
-
-
-
-
-
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
-
-
-
-
-
-
-
Medigen, Dynavax (DVAX) Roll-Out COVID-19 Vaccine
-
-
-
-
-
-
-
Dynavax (DVAX) Announces Publication of HEPLISAV-B ACIP Recommendations in CDC Morbidity & Mortality Weekly Report
-
-
-
-
-
-
-
Dynavax (DVAX) Launches HEPLISAV-B in U.S. for Hep B
-
-
-
-
-
-
-
Dynavax (DVAX) Says FDA Requested More Info on HEPLISAV-B
-
-
-
-
-
-
-
Dynavax Reports First Quarter 2017 Financial Results
-
-
-
-
-
-
-
Dynavax (DVAX) Restructures, to Focus on Immuno-Oncology Program
-
15,404 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

